Vyloy (Zolbetuximab) is a new cancer medicine used for gastric cancer and gastroesophageal junction cancer (GEJ), it targets a protein called Claudin 18.2 on cancer cells, kills the cancer cells
Generic name: zolbetuximab-clzb
Dosage form: Injection (100 mg lyophilized powder in a single-dose vial.)
Drug class: Miscellaneous antineoplastics